| 摘要 |
Compounds of formula (I) or pharmaceutically acceptable salts thereof: <CHEM> wherein: R1 is hydrogen, C1-6 alkyl, phenyl or phenyl C1-4 alkyl wherein the phenyl moiety is optionally substituted by one or more C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, hydroxy, C2-7 alkanoyl, halo, trifluoromethyl, nitro, amino optionally substituted by one or two C1-6 alkyl groups or by C2-7 alkanoyl, cyano, carbamoyl or carboxy groups; R2, R3 and R4 are independently selected from hydrogen, C1-6 alkyl, C1-6 alkoxycarbonyl, C1-6 alkylthio, C2-7 alkanoyl, trifluoromethyl, cyano, carbamoyl and carboxy, and phenyl or phenyl C1-4 alkyl in which any phenyl moiety is optionally substituted by C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxycarbonyl, C1-6 alkylthio, hydroxy, C2-7 alkanoyl, chloro, fluoro, trifluoromethyl, nitro or amino optionally substituted by one or two C1-6 alkyl groups or by C2-7 alkanoyl, cyano, carbamoyl and carboxy; R5 and R6 are independently selected from hydrogen, C1-6 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl-C1-4 alkyl, C2-6 alkenyl, C1-7 alkanoyl, C1-6 alkylsulphonyl, di-(C1-6 alkyl)amino C1-6 alkyl, 3-oxobutyl, 3-hydroxybutyl, phenyl, phenyl C1-4 alkyl, benzoyl, phenyl C2-7 alkanoyl or benzenesulphonyl any of which phenyl moieties are optionally substituted by one or two halogen, C1-6 alkyl, C1-6 alkoxy, CF3, amino or carboxy, or R5 and R6 together are C2-6 polymethylene optionally interrupted by oxygen or NR8 wherein R8 is hydrogen or C1-6 alkyl optionally substituted by hydroxy; and -CO2R7 is a pharmaceutically acceptable ester group, are provided for use in the treatment or prophylaxis of CNS disorders, in particular anxiety or depression. |
